Case Report: Aplastic anemia associated with parvovirus B19 infection following neoadjuvant pembrolizumab-based chemoimmunotherapy for triple-negative breast cancer - Quiz - MDSpire

Case Report: Aplastic anemia associated with parvovirus B19 infection following neoadjuvant pembrolizumab-based chemoimmunotherapy for triple-negative breast cancer

  • By

  • Jan Kindl

  • Dominika Svobodová

  • Martin Matějů

  • Martina Zimovjanová

  • Michal Vočka

  • Petra Kovaříková

  • Zuzana Bielčiková

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Case Report: Aplastic anemia associated with parvovirus B19 infection following neoadjuvant pembrolizumab-based chemoimmunotherapy for triple-negative breast cancer

  • by Jan Kindl, Dominika Svobodová, Martin Matějů, Martina Zimovjanová, Michal Vočka, Petra Kovaříková, Zuzana Bielčiková

  • July 10, 2026

Related Content

Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis

Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review

ASCO26: Sara Tolaney, MD, MPH, ASCENT-03

Dana-Farber Cancer Institute's Dr. Sara Tolaney from the ASCENT-03 stud in breast cancer. The data further strengthens the case for approval of sacituzumab govitecan as first-line treatment for patients with advanced triple-negative breast cancer.

  • July 1, 2026

  • 1 min